Invitrogen Takes Minority Stake in Cell Therapy Company
The investment signals Invitrogen’s strategy to invest in companies using its products in order to gain application and product development expertise.
Carlsbad, CA 2/15/08—Invitrogen has acquired a minority equity share in Q Therapeutics, a company developing cell therapeutic indications for the central nervous system (CNS) by purifying, culturing and growing populations of differentiated CNS cells for injection into patients.
< Previous Article | Next Article >

